Zephase Therapeutics Private Limited - Company Profile

It is a research & development private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Zephase Therapeutics Private Limited

Zephase Therapeutics Private Limited, a struck off private limited company, was established on 09 May 2011 in Hyderabad, Telangana, India. Engaging in research & development within the research & development sector, it holds CIN: U73100TG2011PTC074375. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Kiranam Chatti (Director), Pushkar Kulkarni (Director). Past directors included Javed Iqbal, Randall Theodore Peterson. Its latest AGM occurred on 27 April 2016, with the balance sheet filed on 31 March 2016. It is based at Survey No. 25, Part-1-9, Ils Building University Of Hyderabad Campus, Gachibow, Li, Hyderabad, Telangana, 500046.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100TG2011PTC074375

  • Registration Number

    074375

  • Incorporation Date

    09 May 2011

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 9 Months
  • Last Filing with ROC 31 Mar 2016
Company report

Zephase Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Zephase Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Zephase Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Kiranam Chatti Director 09 May 2011 Current
Pushkar Kulkarni Director 09 May 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Dec 2013 Past
Pramod Abcsdd Director 30 Mar 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zephase Therapeutics.

Enhance accessibility to Zephase Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Zephase Therapeutics revenue growth over time
Zephase Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zephase Therapeutics?

In 2016, Zephase Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zephase Therapeutics?

Unlock and access historical data on people associated with Zephase Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zephase Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zephase Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zephase Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Zephase Therapeutics Private Limited last Annual general meeting of members was held on 27 Apr 2016 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Zephase Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Kiranam Chatti was appointed as a Director was appointed as a Director on 09 May 2011 & has been associated with this company since 14 years 9 months . was documented.

  • Director Appointment

    Progress on Pushkar Kulkarni was appointed as a Director was appointed as a Director on 09 May 2011 & has been associated with this company since 14 years 9 months . was documented.

  • Company Incorporation

    Zephase Therapeutics Private Limited was registered on 09 May 2011 with Roc Hyderabad & aged 14 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zephase Therapeutics Private Limited?

The CIN of Zephase Therapeutics Private Limited is U73100TG2011PTC074375.

Where is Zephase Therapeutics Private Limited headquartered?

Zephase Therapeutics Private Limited is headquartered at Survey No. 25, Part-1-9, Ils Building University Of Hyderabad Campus, Gachibow, Li, Hyderabad, Telangana, 500046.

When was Zephase Therapeutics Private Limited incorporated?

Zephase Therapeutics Private Limited was incorporated on 09 May 2011.

Who are the current directors of Zephase Therapeutics Private Limited?

The current directors of Zephase Therapeutics Private Limited are

What is the primary industry of Zephase Therapeutics Private Limited?

The primary industry of Zephase Therapeutics Private Limited is Research & Development.

Is Zephase Therapeutics Private Limited a listed company?

Zephase Therapeutics Private Limited is unlisted.

What is the capital structure of Zephase Therapeutics Private Limited?

The authorized capital of Zephase Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available